Abstract
The present invention relates to human CCR8 (hCCR8) binders, wherein the hCCR8 binder is a non-blocking binder of hCCR8. Such binders are particularly useful for the depletion of intra-tumoural regulatory T-cells and immunotherapy in general tumour
| Original language | English |
|---|---|
| Patent number | EP4267618 |
| Publication status | Published - 2023 |